Stock ASIA ASIA GREEN BIOTECHNOLOGY CORP.
Add to a list
To use this feature you must be a member
Log inSign up

News Asia Green Biotechnology Corp.

Equities

ASIA

CA04522C1041

Delayed Canadian Securities Exchange
Other stock markets
 01:34:38 2024-02-06 pm EST 		5-day change 1st Jan Change
0.015 CAD +50.00% Intraday chart for Asia Green Biotechnology Corp. -.--% +50.00%
May. 29 Asia Green Biotechnology Corp. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
May. 24 Asia Green Biotechnology Corp. Announces Vincent Ghazar Resigns as Director CI

Summary

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Asia Green Biotechnology Corp. Reports Earnings Results for the First Quarter Ended March 31, 2024
CI
Asia Green Biotechnology Corp. Announces Vincent Ghazar Resigns as Director
CI
Asia Green Biotechnology Corp. Announces Resignation of Vincent Ghazar as Chief Financial Officer
CI
Asia Green Biotechnology Corp. Reports Earnings Results for the Full Year Ended December 31, 2023
CI
Asia Green Biotechnology Corp. Announces Discontinuation of Any Further Activities in Asia, in Particular, in Cambodia and Thailand
CI
CSE Bulletin: Halted for Fundamental Change - Asia Green Biotechnology Corp. (ASIA)
NE
Burton Growers Ltd. & Green Sight Agri-Holdings Inc. entered into a non-binding letter of intent to acquire Asia Green Biotechnology Corp. for CAD 4 million in a reverse merger transaction.
CI
Canadian Investment Regulatory Organization Trading Halt - ASIA
AQ
Asia Green Biotechnology Corp. announced that it expects to receive CAD 1.5 million in funding
CI
Asia Green Biotechnology Corp. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023
CI
Asia Green Biotechnology Corp. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023
CI
Asia Green Biotechnology Corp. Announces Passing of Johannes Kingma, Director
CI
Asia Green Biotechnology Corp. Reports Earnings Results for the First Quarter Ended March 31, 2023
CI
Asia Green Biotechnology Corp. Partners with Pathway Rx Inc. to Pursue Clinical Trials Activities in the Development of A Migraine Treatment Utilizing Cannabis and Hemp Extracts Controlled by Pathway Inc
CI
Asia Green Biotechnology Corp. Announces Resignation of Daryl Hudson as Director
CI
Asia Green Biotechnology Corp. Auditor Raises 'Going Concern' Doubt
CI
Asia Green Biotechnology Corp. Reports Earnings Results for the Full Year Ended December 31, 2022
CI
Asia Green Biotechnology Corp. Proceeds to Next Phase of Migraine Clinical Study
CI
Asia Green Biotechnology Corp. Proceeding to Next Phase of Migraine Clinical Study; Extending Financing Arrangement
MT
Asia Green Biotechnology Corp. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. ASIA Stock
  4. News Asia Green Biotechnology Corp.